Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a
Dove Medical Systems has introduced a new bone densitometer inits OsteoAnalyzer line that is designed to provide low-cost bonemineral density exams. The system, SXA 3000, sells for under $20,000and measures bone density in the heel at the push of a singlebutton, according to the Newbury Park, CA, company.
Earlier this year, Dove signed a deal with Merck in which thatpharmaceutical firm will provide equipment financing support forphysicians purchasing Dove bone densitometers. Merck, which ismarketing its Fosamax drug for the treatment of osteoporosis,has signed similar deals with a number of other bone densitometryvendors (SCAN 2/14/96 and 7/6/95).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.